Ingalls & Snyder LLC’s Amgen AMGN Stock Holding History

Ingalls & Snyder LLC’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-500	Closed	-$134K	–	443
2023 Q3	$134K	Hold	500	–	–	0.01%	400
2023 Q2	$111K	Hold	500	–	–	0.01%	411
2023 Q1	$121K	Hold	500	–	–	0.01%	401
2022 Q4	$131K	Sell	500 -9,200	-95%	-$2.47M	0.01%	409
2022 Q3	$2.19M	Hold	9,700	–	–	0.12%	125
2022 Q2	$2.36M	Hold	9,700	–	–	0.12%	129
2022 Q1	$2.35M	Hold	9,700	–	–	0.1%	139
2021 Q4	$2.18M	Buy	9,700 +500	+5%	+$106K	0.1%	154
2021 Q3	$1.96M	Hold	9,200	–	–	0.09%	164
2021 Q2	$2.24M	Hold	9,200	–	–	0.1%	155
2021 Q1	$2.29M	Buy	+9,200	New	+$2.2M	0.11%	149
2018 Q4	–	Sell	-1,900	Closed	-$394K	–	415
2018 Q3	$394K	Hold	1,900	–	–	0.02%	326
2018 Q2	$351K	Hold	1,900	–	–	0.02%	310
2018 Q1	$324K	Hold	1,900	–	–	0.02%	314
2017 Q4	$330K	Buy	+1,900	New	+$336K	0.02%	315
2017 Q2	–	Sell	-1,900	Closed	-$312K	–	375
2017 Q1	$312K	Hold	1,900	–	–	0.02%	310
2016 Q4	$278K	Buy	+1,900	New	+$286K	0.02%	328

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ingalls & Snyder LLC's AMGN Position: Q1 2026 in Review

Ingalls & Snyder LLC reduced its Amgen (AMGN) stake by 0.37% in Q1 2026, selling an estimated $20K and leaving 14,937 shares worth $5.26M. The position accounts for 0.19% of the portfolio, ranked #97.

Ingalls & Snyder LLC first reported a position in AMGN in Q2 2013 and has held it in 48 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Ingalls & Snyder LLC held 14,937 shares of Amgen worth $5.26M as of Q1 2026.
Ingalls & Snyder LLC sold 56 Amgen shares in Q1 2026, an estimated $20K.
Amgen made up 0.19% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #97 holding.
Ingalls & Snyder LLC first reported a position in Amgen in Q2 2013 and has held it in 48 quarters since.
3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.